================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                   FORM 1O-QSB



/X/      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
         EXCHANGE ACT OF 1934.

                       FOR THE QUARTER ENDED June 30, 2007

                         COMMISSION FILE NO. 333-107826

                        PATIENT PORTAL TECHNOLOGIES, INC.
                        ---------------------------------
             (Exact name of registrant as specified in its charter)

          DELAWARE                                          02-0656132
------------------------------                         ---------------------
State or other jurisdiction of                           I.R.S. Employer
incorporation or organization)                         Identification Number)

7108 Fairway Drive, Palm Beach Gardens, FL                    33418
- ------------------------------------------------     ---------------------
(Address of principal executive offices)                    (Zip Code)

                                 (561) 630-7688
                           (Issuer's Telephone Number)

         Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934, during the preceding 12 months (or for shorter period that the registrant
was required to file such report), and (2) has been subject to such filing
requirements for the past 90 days.   Yes X    No
                                         ---    ---

      Transitional Small Business Disclosure Format: Yes     No  X
                                                         ---    ---

         Indicate by check mark whether the Registrant is a shell company [as
defined in Rule 12b-2 of the Exchange Act]. Yes: No: X
                                                 ---     ---

         The number of shares outstanding of each of the registrant's classes of
common  stock as of  August  1, 2007 is  25,286,601Z  shares of $.001 par value
Common  Stock and 110,000  Shares of Class A  Redeemable  Convertible  Preferred
Stock, $.01 par value.




<PAGE>

                        PATIENT PORTAL TECHNOLOGIES, INC.


                                      INDEX

                                                                            PAGE


PART I  FINANCIAL INFORMATION - Unaudited

Consolidated Balance Sheet-June 30,  2007.....................................1

Consolidated Statements of Operations-Three Months
  Ended June 30, 2007  and 2006...............................................2

Consolidated Statement of Stockholder's Equity (Deficit) -
  Three Months Ended June 30, 2007............................................3

Consolidated Statement of Cash Flows-Three Months
  Ended June 30, 2007  and 2006...............................................4

Notes to the Consolidated Financial Statements................................5

Management's Discussion and Analysis of Financial
Condition and Results of Operations..........................................16

PART II OTHER INFORMATION

Item 1. Legal Proceedings....................................................24

Item 2. Changes in Securities................................................24

Item 3. Defaults Upon Senior Securities......................................24

Item 4. Submission of Matters to a Vote of Security Holders..................24

Item 5. Other Information....................................................24

Item 6. Exhibits on Reports on Form 8-K......................................24

Signature Page...............................................................25



                                      -i-


<PAGE>
                PATIENT PORTAL TECHNOLOGIES, INC., AND SUBSIDIARY
                           CONSOLIDATED BALANCE SHEET
                                  JUNE 30, 2007
                                   (Unaudited)

                                     ASSETS

CURRENT ASSETS:
  Cash and cash equivalents                                    $        40,689
  Accounts Receivable                                                    1,935
  Other Receivables                                                          0
  Prepaid Expenses                                                      70,413
  Inventory                                                                  0

                                                               ---------------
      TOTAL CURRENT ASSETS                                             113,037

PROPERTY, PLANT AND EQUIPMENT, net                                     810,132

HOSPITAL CONTRACTS, net                                              1,653,922

LONG-TERM NOTE RECEIVABLE                                              250,000
                                                               ---------------

      TOTAL ASSETS                                             $     2,827,091
                                                               ===============

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:
  Accounts payable                                                     18,703
  Notes Payable                                                        387,317
  Note Payable, Related Party                                          212,012
  Note Payable, Shareholder                                             50,000
  Accrued Liabilities                                                    1,693
  Other current liabilities                                                  0
                                                               ---------------
      TOTAL CURRENT LIABILITIES                                        669,725
                                                               ---------------

REDEEMABLE PREFERRED STOCK, $.01 par value, authorized
  1,000,000:Issued 110,000 shares, at par value
  Present value of redemption amount in excess                           1,100
    of par value
                                                               ---------------
STOCKHOLDERS' EQUITY:
  Common stock, $.001 par value, authorized:
    100,000,000; 25,286,601 shares
    issued and outstanding at June 30, 2007                             25,286
  Additional paid-in-capital                                         5,249,961
  Retained deficit                                                  (3,118,981)
                                                               ---------------
      TOTAL STOCKHOLDERS' EQUITY                                     2,157,366
                                                               ---------------
      TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                     2,827,091
                                                               ===============


See notes to the consolidated financial statements.



                                      -1-
<PAGE>

                PATIENT PORTAL TECHNOLOGIES, INC. AND SUBSIDIARY
                      CONSOLIDATED STATEMENTS OF OPERATIONS


                               Three Months Ended          Six Months Ended
                                    June 30,                   June 30
                                  (Unaudited)                (Unaudited)
                               2006         2007         2006           20007
                            ----------  -----------   -----------  -------------
NET SALES                            -  $   391,856             -  $    634,834

COST OF SALES                        -      273,384             -       469,068
                            ----------  -----------   -----------  -------------

GROSS PROFIT                         -      118,472             -  $    165,766
                            ----------  -----------   -----------  -------------

DIRECT OPERATING EXPENSES:
  Sales and marketing                -      144,653             -       234,706
  Research and Development                   24,624             -        53,678
  Administration                35,000                $    70,000             -
                            ----------  -----------   -----------  -------------

TOTAL OPERATING EXPENSES        35,000      169,277   $    70,000  $    288,384
                            ----------  -----------   -----------  -------------

(LOSS) FROM OPERATIONS
   BEFORE OTHER INCOME
   AND EXPENSE                 (35,000)     (50,805)  $   (70,000) $   (122,618)
                            ----------  -----------   -----------  -------------

OTHER INCOME AND EXPENSES
  Start Up and
  Re-alignment Costs
  Interest Costs (net)               -        1,693             -         1,693
  Depreciation Expense               -       43,335             -        86,670
  Amortization Expense                       87,048             -        87,048
                            ----------  -----------   -----------  -------------

TOTAL OTHER INCOME/EXPENSES          -     (132,076)            -      (175,411)

OPERATING LOSS BEFORE TAXES    (35,000)    (182,881)  $   (70,000) $   (298,029)

PROVISION FOR INCOME TAX            --           --             -             -
                            ----------  -----------   -----------  -------------

NET (LOSS)                  $  (35,000)    (182,881)  $   (70,000)    ($298,029)
                            ==========  ===========   ===========  =============


Net Loss per share:         $     (.01) $      (.01)  $      (.01) $       (.01)
                            ==========  ===========   ===========  =============

Common shares outstanding    9,979,479   25,286,601     9,979,479     25,286,601
                            ==========  ===========   ===========  =============

See notes to the consolidated financial statements.



                                      -2-
<PAGE>

                PATIENT PORTAL TECHNOLOGIES, INC. AND SUBSIDIARY
            CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY


                                 Common
                                 Stock     Additional
                                 $.001      Paid-In      Retained
                      Shares    Par Value   Capital       Deficit       Total
                    ----------- ---------  -----------  -----------  ----------
Balance March 31,    24,136,601 $  28,821  $ 3,926,130  $(2,936,100) $1,018,831
  2007

Issuance of shares
 for services and
 assets               1,150.000 $   1,150  $ 1,320,266               $1,321,416

Issuance of warrants
 for services                --        --  $        --

Issuance of common
 stock pursuant to
 exercise of
 warrants                    -- $      --  $        --

Net loss for the
 three months
 ended June 30,
 2007 (Unaudited)            --        --           --  $  (182,881)  ($182,881)
                    ----------- ---------  -----------  ------------ -----------

Balance June 30,
 2007 (Unaudited)   25,286,601  $  29,971  $ 5,246,396  $(3,118,981) $ 2,157,366
                    ==========  =========  ===========  ============ ===========




See notes to the consolidated financial statements.



                                      -3-
<PAGE>

                  PATIENT PORTAL TECHNOLOGIES, INC. AND SUBSIDIARY
                      CONSOLIDATED STATEMENTS OF CASH FLOWS

                                                          Six Months Ended
                                                               June 30,
                                                             (Unaudited)
                                                         2007            2006
                                                      -----------     ---------
OPERATING ACTIVITIES:
  Net Income (Loss)                                   $  (298,029)    $ (46,966)
Adjustments to reconcile net income (loss)
  to net cash provided by operations:
  Common stock and Warrants issued for services                --            --
  Depreciation and amortization                           173,718            --
  Book value of assets disposed                                --            --
  Bad debt                                                     --            --
  (Increase) decrease in assets:
    Accounts receivable                                   ( 1,935)          869
    Inventory                                                            17,318
    Other current assets- prepaid expenses                (70,413)        7,500
    Other assets                                               --            --
  Increase (decrease) in liabilities:
    Accounts payable                                      (18,704)      118,832
    Accrued expenses -                                                   (7,250)
    Accrued expenses - other                               13,131        (5,844)
    Note Payable                                           50,000            --
                                                      -----------     ---------

      Total adjustments                               $  (152,232)      144,150
                                                      -----------     ---------

NET CASH (USED IN) OPERATING ACTIVITIES               $  (152,232)       (3,980)
                                                      -----------     ---------
INVESTING ACTIVITIES:
  Purchase of fixed assets                            $    (3,159)           --
  Purchase Retail Hospital Contracts                  $(1,653,922)
                                                      -----------     ---------

NET CASH FLOWS (USED IN) INVESTING ACTIVITIES         $(1,657,081)           --
                                                      -----------     ---------
FINANCING ACTIVITIES:
  Issuance of Preferred Stock                         $   537,499            --
  Issuance of Common Stock                            $ 1,119,582
                                                      -----------     ---------
NET CASH FLOWS PROVIDED BY (USED IN)
  FINANCING ACTIVITIES                                $ 1,628,472            --
                                                      -----------     ---------
NET INCREASE (DECREASE) IN CASH                            28,609        (3,980)

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD             12,080         4,722
                                                      -----------     ---------
CASH AND CASH EQUIVALENTS, END OF PERIOD              $    40,689     $     742
                                                      ===========     =========

See notes to the consolidated financial statements.



                                      -4-
<PAGE>

                           PATIENT PORTAL TECHNOLOGIES, INC.
                                 And SUBSIDIARY
                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)


NOTE 1 -- GOING CONCERN

         As shown in the Company's Annual financial statements, the Company
incurred a net loss of ($401,408) during the year ended December 31, 2006 and
($182,881) during the three months ended June 30, 2007. Additionally, the
Company had a stockholders' equity of $717,977 during the year ended December
31, 2006 and $2,157,366 at June 30, 2007; however, its working capital at that
time is not sufficient to support the Company's losses from operations at
existing levels for the next year. The Company plans to raise more capital
through public or private financing, through the issuance of its common stock,
the issuance of debt instruments, including debt conve3rtible to equity, or
otherwise attain financing, which if available, it cannot be certain such
financing will be on attractive terms. Should the Company obtain more capital,
in turn, it may cause dilution to its existing stockholders and providing the
company can obtain more capital, it cannot be assured to ultimately attain
profitability. These factors create substantial doubt as to the Company's
ability to continue as a going concern.

         The Company intends to continue its efforts to complete the necessary
steps in order to meet its cash flow requirements throughout fiscal 2007 and to
continue its product development efforts and adjust its operating structure to
reduce losses and ultimately attain profitability. Management's plans in this
regard include, but are not limited to, the following:

         1. Raise additional working capital by either borrower or through the
issuance of equity, or both;

         2. Negotiate terms with existing trade creditors and strategic vendors;
negotiate an alliance with strategic co-ventures for stronger distribution
channels in the health care markets.

         3. Re-align revenue producing activities and corresponding commission
arrangements on such a scale that will proportionately reduce selling expenses
and reduce other costs wherever possible to improve operating margins and
relieve the overhead burden until ultimately profitability may be attained.

         Management believes that actions presently being taken will generate
sufficient revenues to provide cash flows from operations and that sufficient
capital will be available, when required, to permit the Company to realize its
plans. However, there can be no assurance that this will occur. The accompanying
financial statements do not include any adjustments that might result from the
outcome of this uncertainty.



                                      -5-
<PAGE>

                        PATIENT PORTAL TECHNOLOGIES, INC.
                                 And SUBSIDIARY
                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)



NOTE 2 -- ORGANIZATION AND NATURE OF BUSINESS AND SIGNIFICANT ACCOUNTING
POLICIES

         PATIENT PORTAL TECHNOLOGIES, INC. (the "Company") organized under the
laws of the State of Delaware, in November, 2002. The Company was formerly a
sun-care and skin-care company specializing in the development, manufacture and
sale of all-natural sun-, skin-, and body-care products to the resort, boutique,
spa and natural health markets.

         Effective December 31, 2002, the Company acquired a 60% ownership
position in Caribbean Pacific Natural Products, Inc., ("Caribbean Pacific
Natural Products") which is a developer and marketer of all-natural sun-care and
skincare products for luxury resorts, theme parks and spas. In December 2002,
the Board of Directors of The Quigley Corporation ("Quigley") approved a plan to
sell Caribbean Pacific Natural Products and on January 22, 2003, completed the
sale of Quigley's 60% equity interest in Caribbean Pacific Natural Products to
the Company.

         Effective September 28, 2005, the Company sold its entire equity
interest in Caribbean Pacific Natural Products, Inc. and CP Suncoast
Manufacturing, Inc. to Suncoast Nutriceuticals, Inc. (SNI) in exchange for a
two-year Promissory Note in the principal amount of $250,000 and 3,500,000
Shares of Common Stock of SNI. The assets and liabilities attributable to the
two subsidiaries were assumed by SNI as a result of this transaction.

         On December 8, 2006, the Registrant acquired 100% of the capital stock
of Patient Portal Connect, Inc. of Palm Beach Gardens, FL through the issuance
of 17,500,000 shares of Common Stock of the Company to the shareholders of
Patient Portal Connect, Inc. in a tax-free share exchange. As a result of this
transaction, Patient Portal Connect, Inc. became a wholly-owned operating
subsidiary of the Company.

BASIS OF PRESENTATION

         The Consolidated Financial Statements include the accounts of the
Company and its 60% owned subsidiary, Caribbean Pacific Natural Products, Inc.
All inter-company transactions and balances have been eliminated. In the opinion
of management, all adjustments necessary to present fairly the consolidated
financial position, consolidated results of operations and consolidated cash
flows, for the periods indicated, have been made. Certain prior period amounts
have been reclassified to conform with the 2002 presentation.


                                      -6-
<PAGE>

                        PATIENT PORTAL TECHNOLOGIES, INC.
                                 And SUBSIDIARY
                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)


RECAPITALIZATION OF CARIBBEAN PACIFIC NATURAL PRODUCTS, INC.

         Material sales and expenses included in prior consolidated financial
statements of the Company resulted from the inclusion of financial information
of the Company's 60% owned subsidiary Caribbean Natural Products, Inc.
("Caribbean Pacific Natural Product"), which is a developer and marketer of
all-natural sun-car and skincare products for luxury resorts, theme parks and
spas. In December 2002, the Board of Directors of the Company approved a plan to
acquire Caribbean Pacific Natural Products. On January 22, 2003, the Company
acquired a 60% equity interest in Caribbean Pacific Natural Products. In
exchange for its 50% equity interest in Caribbean Pacific Natural Products, the
Company issued to the Quigley Corporation: (I) 750,000 shares of the Company's
common stock, which Suncoast has agreed, at its cost, to register for public
resale through an appropriate registration statement; and (ii) 100,000 shares of
Suncoast's Series A Redeemable Preferred Stock, which bears certain redemption
features discussed in Note 6 - Redeemable Preferred Stock.

         Pursuant to SFAS No. 141, which applies to business combinations after
September 30, 2001, which requires the use of the purchase method of accounting
for all business combinations, carrying forward the guidance from APB 16 with
respect to: (a) the principles of historical cost accounting; (b) determining
the cost of the acquired entity; and (C) allocation of cost to assets and
liabilities assumed; "Caribbean Pacific Natural Products" is considered the
acquiring entity. As such the historical balances of "Caribbean Pacific Natural
Products" assets and liabilities representing the carrying value and
corresponding allocation of the purchase price, and therefore, the transaction
is equivalent to a reverse acquisition, which in this case, no partial step up
in asset values discussed in EITF 90-3 apply, and thereby no goodwill or
intangible assets have been recorded. The equity issued by the Company was
valued at the (a) present value of the redeemable preferred shares issued to
"Quigley" and (b) common stock and additional paid in capital was recorded to
the value of the remaining liability to "Quigley" cancelled by the exchange
agreement.

ACCOUNTING FOR BUSINESS COMBINATION OF CARIBBEAN PACIFIC NATURAL PRODUCTS,
APPLICATION OF SAB 103

         During the years ended December 31, 2000, 2001 and 2002, the results of
operations, cash flows and assets and liabilities of Caribbean Pacific Natural
Products were included in the consolidated financial statements of the Quigley
Corporation, the effect of which were reported as discontinued operations in
2002. The financial statements of "Quigley" were audited by another auditor, and
the results of this subsidiary were not reported separately. Recently the staff
of Corporate Finance Division of the Securities and Exchange Commssio0n, "SEC,"
provided guidance in the codification of its staff accounting bulletins ("SABS")






                                      -7-
<PAGE>

                        PATIENT PORTAL TECHNOLOGIES, INC.
                                 And SUBSIDIARY
                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)



and in discussion of accounting for former subsidiaries, such as the case with
Caribbean Pacific Natural Products, indicated that reasonable estimates for
expenses of the use of a parent company's capital (I.e. interest) and other
corporate charges connected with operating as a stand alone entity (including
legal fees, audit fees and administrative expenses) should be estimated when the
division or subsidiary is presented individually. Caribbean Pacific Natural
Products was divested by the Company on September 28, 2005. The financial
statements include such estimates and additional expenses were recorded, and a
like amount was credited to additional paid in capital for the periods presented
as follows:

                                                       Year Ended
                                                      December 31,
                                             -------------------------------
                                                2006                 2005
                                             (Audited)
                                             -------------------------------

Interest Costs                               $  126,152            $  25,653
Administrative costs                         $                     $  90,000
                                             -------------------------------
                                             $  126,152            $ 115,653
                                             ===============================

PROPERTY, PLANT AND EQUIPMENT

         Property  plant and  equipment  is recorded at cost.  Depreciation  is
provided on the  straight-line  method over  estimated  useful lives of three to
five years.

INVENTORIES

         While  inventories were stated at the lower of cost or market,  and the
Company used the first-in, first-out ("FIFO") method of determining cost for all
inventories,  inentories  were sold as of September  30, 2005, at the time that
the subsidiary was sold.

USE OF ESTIMATES

         The  preparation of financial  statements in conformity  with generally
accepted  accouting  principles  requires  management  to  make  estimates  and
assumptions  that  affect the  reported  amounts of assets and  liabilities  and
disclosure of contingent  liabilities  at the dates of the financial  statements
and the reported amounts of revenues and expenses during the reporting  periods.
Actual results could differ from those estimates.




                                      -8-
<PAGE>

                        PATIENT PORTAL TECHNOLOGIES, INC.
                                 And SUBSIDIARY
                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)



CASH EQUIVALENTS

         The Company considers all highly liquid investments with an initial
maturity of three months or less at the time of purchase to be cash equivalents.
Cash equivalents include cash on hand and monies invested in money market funds.
The carrying amount approximates the fair market value due to the short-term
maturity of these investments.

FAIR VALUE OF FINANCIAL INSTRUMENTS

         The Company's carrying amounts reported in the consolidated balance
sheets for cash, accounts receivable, accounts payable and accrued expenses
approximate their fair values due to the short maturities of these financial
instruments. The carrying amounts reported n the consolidated balance sheets for
long-term debt due to related parties approximate their fair values as they
represent the amount the Company expects to liquidate these obligations with
cash or cash equivalents, and the amounts recorded as other liabilities -
redeemable preferred stock approximate their fair value as they represent the
amount in which the Company expects to satisfy these obligations by payment in
cash in 2007 or by the issuance of the Company's equity without material gain or
loss.

REVENUE RECOGNITION

         Sales are recognized at the time ownership is transferred to the
customer, which is primarily the time the shipment is received by the customer.
In limited instances, selected trial periods, whereby the customer has the right
of return until the selected trial period ends, the Company recognizes revenue
when the trial period ends and no right of return exists.

         Sales returns and allowances are provided for in the period that the
related sales are recorded. Provisions for these reserves are based on
historical experience.

         As required, effective January 1, 2003, the Company has adopted the
Securities and Exchange Commission ("SEC") Staff Accounting Bulletin ("SAB") No.
101, "Revenue Recognition in Financial Statements" which provides guidelines on
applying generally accepted accounting principals to revenue recognition based
upon the interpretations and practices of the SEC. The Company recognizes
revenue for its products at the time of shipment, at which time, no other
significant obligations of the Company exist, other than normal product
warranties.

SHIPPING AND HANDLING

         The Company includes costs of shipping and handling billed to customers
in revenue and the expense of shipping and handling costs is included in cost of
sales.



                                      -9-
<PAGE>

                        PATIENT PORTAL TECHNOLOGIES, INC.
                                 And SUBSIDIARY
                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)


STOCK BASED COMPENSATION

         Financial Accounting Statement No. 123, Accounting for tock Based
Compensation, encourages, but does not require companies to record compensation
cost for stock-based employee compensation plans at fair value. Through December
31, 2003, the Company had chosen to account for stock-based compensation using
the intrinsic method prescribed in Accounting Principles Board Opinion No. 25,
Accounting for Stock Issued to Employees, and related interpretations.
Accordingly, compensation cost for stock options issued through December 31,
2003, was measured as the excess, if any, of the quoted market price of the
Company's stock at the date of the grant over the amount an employee must pay to
acquire the stock.

         Effective for the fiscal years ended December 31, 2004, and for
December 31, 2006, the Company has adopted the fair value method of accounting
described in SFAS 123 and SFAS 148.

ADVERTISING

         Advertising costs are expensed within the period in which they are
utilized. Advertising expense is comprised of media advertising, presented as
part of sales and marketing expense; co-operative advertising, which will be
accounted for as a deduction from sales; and free product, which is accounted
for as part of cost of sales. No advertising costs were incurred for the
year-ended December 31, 2005.

INCOME TAXES

         The Company utilizes an asset and liability approach which requires the
recognition of deferred tax assets and liabilities for the future tax
consequences of events that have been recognized in the Company's financial
statements or tax returns. In estimating future tax consequences, the Company
generally considers all expected future events other than enactments of changes
in the tax law or rates. See Notes to Financial Statements, Note 7 - Income
Taxes for further discussion.

START-UP AND RE-ALIGNMENT COSTS

         Pursuant to Statement of Position 98-5, the Company expenses start-up
costs associated with its parent company's activation activities and costs and
expenses incurred in connection with the acquisition of Caribbean Pacific
Natural Products, which pursuant to FASB 142 and APB 16, were expensed as
transaction costs. The Statement of Position broadly defines start-up activities
as activities associated with, opening a new facility, introducing new products




                                      -10-
<PAGE>
                        PATIENT PORTAL TECHNOLOGIES, INC.
                                 And SUBSIDIARY
                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)



or services, conducting business with a new class of customers or in a new
territory, and starting a new process in an existing facility or starting a new
operation. Re-alignment costs are costs associated with changing the contractual
distribution agreements to an existing customer base. Start up and re-alignment
costs for the years ended December 31, 2004 and 2005 were $300,204 and $0
respectively.

MINORITY INTERESTS

         The Company's "Caribbean Pacific Natural Products" subsidiary is 40%
owned by a related party whom has made a nominal investment, of which losses
since inception have reduced the investment to a value of $0. The Company has
not recorded earnings in the "Caribbean Pacific Natural Products" subsidiary.
Had the Company attained and recorded net income in this subsidiary, 40% would
have been allocated to the minority shareholders, and cumulatively, and had this
subsidiary accumulated earnings in excess of its cumulative losses, the Company
would have recorded amounts allocable to "minority interest," which would be a
reduction of stockholders' equity.

         Effective September 28, 2005, the Company sold its entire equity
interest in Caribbean Pacific Natural Products, Inc. and CP Suncoast
Manufacturing, Inc. to Suncoast Nutriceuticals, Inc. (SNI) in exchange for a
two-year Promissory Note in the principal amount of $250,000 and 3,500,000
Shares of SNI Common Stock. The assets and liabilities attributable to the two
subsidiaries were assumed by SNI as a result of this transaction.

NOTE 3 - INVENTORY

         The Company had no inventory as of June 30, 2007.

NOTE 4 - PROPERTY, PLANT AND EQUIPMENT

         Property, plant and equipment consisted of the following as of:

                                                            June 30, 2007



Machinery and equipment,                                      $  896,802
Computer software and website
                                                              ----------
                                                              $  896,802


Less:  Accumulated depreciation                                  (86,670)
                                                              ----------

Property, Plant and Equipment, net                            $  810,132
                                                              ==========




                                      -11-
<PAGE>

                        PATIENT PORTAL TECHNOLOGIES, INC.
                                 And SUBSIDIARY
                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)



NOTE 5 - SEGMENT INFORMATION

         The Company divested its former operating subsidiary as of September
30, 2005. Prior to that date, the Company had one reporting segment relating to
the sales of all natural sun-care and skincare products for luxury resorts,
theme parks and spas. As defined in SFAS 31, "Disclosures about Segments of an
Enterprise and Related Information," allocate resources and assess the
performance of the Company based on revenue and overall profitability.

         The Company's present operations are conducted solely in the United
States, and all revenues are derived from the operations of the Company's
Wholly-owned Patient Portal Connect, Inc. subsidiary.

NOTE 6 - CONVERTIBLE REDEEMABLE PREFERRED STOCK

         On December 31, 2002, the Company issued 100,000 Shares of Preferred
Stock, designated Class "A" Redeemable Preferred Stock, to The Quigley
Corporation as partial consideration for the acquisition of 60% of the Common
Stock of Caribbean Pacific Natural Products, Inc. All 100,000 of these Shares
were converted by the holder on December 1, 2006 into 850,000 Shares of common
stock.

         During the quarter ended December 31, 2006, the Company sold 60,000
Shares of Preferred Stock, designated Class "A" Convertible Redeemable Preferred
Stock, to six investors for total net consideration of $566,440.

         During the quarter ended March 31, 2007, the Company sold 50,000 Shares
of Preferred Stock, designated Class "A" Convertible Redeemable Preferred Stock,
to five investors for total net consideration of $403,144.

         The holders of the Class A Stock shall be entitled to receive in
preference to the holders of the Corporation's Common Stock, when, as and if
declared by the Corporation's Board of Directors, annual dividends at the rate
of $.10 per share and no more. Dividends on the Class A Stock shall be
cumulative, and declared but unpaid dividends shall not bear interest. The
holders of Class A Stock shall have no voting rights. No other Series or Class
of Preferred Stock which may subsequently be designated or authorized by the
Board of Directors shall be granted or otherwise be entitled to any voting
rights.

         The Corporation shall have the sole right to redeem the shares of Class
A Stock at any time following the date of issuance. The Redemption Price for
each share shall be $12.50 per share plus an interest factor which shall accrue
from the date of issuance through the date of redemption. The interest rate
shall be a fixed annual rate of 10%.




                                      -12-
<PAGE>
                        PATIENT PORTAL TECHNOLOGIES, INC.
                                 And SUBSIDIARY
                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)




NOTE 7 - CAPITAL STOCK TRANSACTIONS

         Significant provisions of the Company's capital stock are highlighted
below and are subject to the provisions of the Company's Certificate of
Incorporation and the Bylaws:

Preferred Stock

         The Company presently authorized to issue up to 1,000,000 shares of
preferred stock, $.01 par value per share. Such preferred stock may be issued in
one or more series on such terms and with such rights, preferences and
designations as our board of directors may determine. Such preferred stock may
be issued without action by stockholders. [See Note 6].

Common Stock

         The Company is presently authorized to issue up to 100,000,000 shares
of common stock, $.001 par value per share. The holders of common stock are
entitled to one vote for each share held of record on each matter submitted to a
vote of stockholders. Subject to the prior rights of any series of preferred
stock which may from time to time be outstanding, holders of common stock are
entitled to receive ratably such dividends as may be declared by our Board of
Directors out of funds legally available therefor, and, upon our liquidation,
dissolution or winding up, they are entitled to share ratably in all assets
remaining after payment of liabilities and payment of accrued dividends and
liquidation preference on the preferred stock, if any. Holders of common stock
have no preemptive rights and have no rights to convert their common stock into
any other securities.

         On September 1, 2006, the Company undertook a reverse-split of its
common stock through the issuance of one new share of common stock for each ten
issued and outstanding shares of common stock.

         On December 1, 2006, the Company issued 850,000 Shares of common stock
to The Quigley Corporation in conversion of its 100,000 Shares of Series A
Redeemable Convertible Preferred Stock.

         On December 1, 2006, the Company issued 1,700,000 shares of common
stock in conversion and satisfaction of $170,000 of outstanding loans payable
and 500,000 shares of common stock in settlement of a contingent liability.

         On December 8, 2006, the Company issued 17,500,000 Shares of its common
stock in exchange for 100% of the issued and outstanding capital stock of
Patient Portal Connect, Inc. and 500,000 shares of common stock in conversion
and satisfaction of $500,000 of short-term loans payable of Patient Portal
Connect, Inc.

         During the year ended December 31, 2006, the Company issued a total of
2,123,652 Shares of Common Stock pursuant to its employment agreements and as
partial compensation for legal and marketing services.

         During the quarter ended June 30, 2007, the Company issued 1,000,000
shares of Common Stock as a portion of the purchase price for certain hospital
contract assets, and a total of 150,000 Shares of Common Stock in lieu of cash
compensation for services rendered and as partial compensation for legal and
marketing services.




                                      -13-
<PAGE>
                        PATIENT PORTAL TECHNOLOGIES, INC.
                                 And SUBSIDIARY
                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)




         WARRANTS AND OPTIONS- As of June 30, 2007, in addition to the Company's
aforesaid outstanding Common Stock, there are issued and outstanding Common
Stock Purchase Warrants which are exercisable at the price-per- share indicated,
and which expire on the date indicated, as follows:

Description                   Number          Exercise Price     Expiration
---------------------------------------------------------------------------
Class "A" Warrants            390,000           $     2.00        12/31/11
Class "B" Warrants            390,000           $     3.00        12/31/11
Class "C" Warrants            390,000           $     4.00        12/31/11
Class "D" Warrants          3,650,000           $      .50        12/31/09

2002 INVENTIVE STOCK OPTION PLAN

         On November 22, 2002, the Shareholders of the Company ratified the
Company's "2002 Incentive Stock Option Plan" and reserved 1,000,000 shares for
issuance pursuant to said Plan. As of June 30, 2007, no options have been
awarded pursuant to this Plan.

Reserved Shares

         The Company has also reserved for insurance up to 1,000,000 shares of
common stock in connection with the 2002 Incentive Stock Option Plan. To date,
no options have been granted under this plan.

NOTE 8 - COMMITMENTS AND CONTINGENCIES

Operating Leases

         During the year ended December 31, 2006 and the quarter ended June 30,
2007, the Company had no equipment or operating leases in effect. The Company
paid a portion of real estate leases on four properties representing primary
office space and company apartments in Palm Beach Gardens, FL and Baldwinsville,
NY. The future minimum non-cancelable lease payments under leases are
$93,427.29, $89,640.00, and $87,840.00 for the three years ended December 31,
2007, 2008, and 2009 respectively. The minimum lease payments for years 2010
through 2015 are $82,240.00 per year. The minimum lease payments for 2016 are
$21,060.



                                      -14-
<PAGE>
                        PATIENT PORTAL TECHNOLOGIES, INC.
                                 And SUBSIDIARY
                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)



Employment Agreements

         As of June 30, 2007, the Company had no Employment Agreements in
effect.

Litigation

         From  time to  time  the  Company  may be  involved  in  various  legal
proceedings  and  other  matters,  including  nominal  disputes  with  creditors
relating to the dollar amount of outstanding obligations of the Company, arising
in the normal  course of business.  The Company  believes no such actions  would
result in liabilities in excess of amounts accrued in the financial statements.

NOTE 9 - RELATED PARTY TRANSACTIONS

         During the period ended June 30, 2007, the Company entered into asset
purchase agreements whereby it acquired certain retail hospital contracts from
Patient Portal, Inc. for the purchase price of $1,245,991.

         During the period ended March 31, 2007, the Company entered into asset
purchase agreements whereby it acquired certain retail hospital contracts from
Patient Portal, Inc. for the purchase price of $407,931.

        During the period  ended  December 31,  2006,  the Company  entered into
asset purchase  agreements  whereby it acquired  certain software and technology
from Paient Portal,  Inc. for the purchase  prices of $750,000 and $63,852.  of
Common Stock pursuant to its employment  agreements and as partial  compensation
for legal and marketing services.

         During the year ended  December  31,  2006,  costs and  expenses of the
Company inlude billings of $5,537.48 from Patient Portal,  Inc. for call-center
services  in  support  of  hospital  service  contracts.  Selling,  General  and
Administrative  expenses include $2,500 from Patient Portal, Inc. for IT support
services. For the quarter ended March 31, 2007, these costs and expenses totaled
$119,107.

        The  controlling  shareholders  of the Company are also the controlling
shareholders  of Patient  Portal,  Inc., and the purchase and sale  transactions
were at market value for the assets acquired.





                                      -15-
<PAGE>

ITEM 6.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND PLAN OF
         OPERATIONS.

         The following is Management's discussion and analysis of certain
significant factors which have affected the Company's financial position and
operating results during the periods included in the accompanying financial
statements, as well as information relating to the plans of the Company's
current management.

FORWARD-LOOKING STATEMENTS

         This report contains "forward-looking statements". In some cases, you
can identify forward-looking statements by terms such as "may," "intend,"
"might," "will," "should," "could," "would," "expect," "believe," "estimate,"
"predict," "potential," or the negative of these terms and similar expressions
intended to identify forward-looking statements. These statements reflect the
Company's current views with respect to future events and are based on
assumptions and subject to risks and uncertainties. These risks and
uncertainties may cause the Company's actual results, performance, or
achievements to be materially different from any future results, performance, or
achievements expressed or implied by the forward-looking statements. You should
not place undue reliance on these forward-looking statements. Also, these
forward-looking statements represent the Company's estimates and assumptions as
of the date of this report. The Company is under no duty to update any of the
forward-looking statements after the date of this report to conform such
statements to actual results or to changes in our expectations.

RESULTS OF OPERATIONS
---------------------

         The Company was established in November, 2002. On December 7, 2006, the
Company acquired Patient Portal Connect, Inc., which at present is its only
operating subsidiary. The results of operations for the three months ended June
30, 2007 includes the business operations of this subsidiary.

Three Months Ended June 30, 2007 vs. June 30, 2006
----------------------------------------------------

         The Company reported no revenue for the three months ended June 30,
2006 due to the divestiture of its former operating subsidiary in September,
2005. In December, 2006, the Company acquired a new operating subsidiary,
Patient Portal Connect, Inc., and the revenues for this reporting period reflect
the revenues of this operating subsidiary. Due to the lack of business
operations during the quarter ended March 31, 2006 there are no year-to-year
comparisons for revenues and expenses.

         Revenues for the three months ended June 30, 2007 were $391,856 and
were derived from hospital service contracts acquired by the Company during this
quarter. Cost of sales for the three months ended June 30, 2007 were $273,384.

         Selling and marketing expenses were $169,277 for the three months ended
June 30, 2007, and Research and Development Expenses were $24,624. Depreciation
and Amortization expenses for this three-month period totaled $130,383.

         The Company reported a net loss of ($182,881) for the three month
period ended June 30, 2007 as compared to a net loss of ($46,966) during the
three months ended June 30, 2006. This represents a loss per share of $.01 for
the three months ended June 30, 2007 as compared to a loss per share of $.01 for
the three months ended June 30, 2006.


Six Months Ended June 30, 2007 vs. June 30, 2006
----------------------------------------------------

         The Company reported no revenue for the six months ended June 30, 2006
due to the divestiture of its former operating subsidiary in September, 2005. In
December, 2006, the Company acquired a new operating subsidiary, Patient Portal
Connect, Inc., and the revenues for this reporting period reflect the revenues
of this operating subsidiary. Due to the lack of business operations during the
six-month period ended June 30, 2006 there are no year-to-year comparisons for
revenues and expenses.

         Revenues for the six months ended June 30, 2007 were $643,834 and were
derived from hospital service contracts acquired by the Company during this
quarter. Cost of sales for the six months ended June 30, 2007 were $469,068.

         Selling and marketing expenses were $234,706 for the three months ended
June 30, 2007, and Research and Development Expenses were $53,678. Depreciation
and Amortization expenses for this six-month period totaled $173,930.



                                      -16-
<PAGE>
         The Company reported a net loss of ($289,241) for the six month period
ended June 30, 2007 as compared to a net loss of ($81,966) during the six months
ended June 30, 2006. This represents a loss per share of $.01 for the six months
ended June 30, 2007 as compared to a loss per share of $.01 for the six months
ended June 30, 2006.


CURRENT PLAN OF OPERATIONS
--------------------------

         Patient Portal Technologies, Inc. through its newly acquired
subsidiary, Patient Portal Connect, Inc. (PPC) is well positioned to be the
premier provider of integrated workflow solutions in the healthcare industry.
Having developed the industry's newest, leading-edge process improvement
delivery platform for the healthcare industry, PPC is poised to capture a
significant segment of the multi-billion dollar healthcare market. Its
proprietary systems were developed in close coordination with hospital industry
partners to provide multi-layer functionality across a wide spectrum of critical
patient-centric workflows that result in immediate improvements in cost savings,
patient outcomes, and revenue growth for hospitals. PPC's revolutionary
solutions are changing the way hospitals and patients do business in today's
healthcare environment.

         Nationwide, an explosive demand for more customized healthcare has
resulted in a greater need for improved productivity, efficiency, and customer
service in hospitals. PPC has pioneered the development of integrated software
applications that combine technology and industry expertise with unique
customization designed to better manage the hospital/patient relationship and
improve hospital operational processes. Further, our solutions enable hospitals
to achieve compliance with strict government mandates that affect reimbursements
by requiring measured improvements in productivity, efficiency, and patient
satisfaction. PPC's proven technologies provide tremendous economic benefit for
healthcare providers.

         PPC intends to rapidly gain market share by leveraging strategic
relationships and acquiring companies with existing hospital contracts. The
company's acquisition strategy will enable it to achieve immediate
profitability, grow rapidly, and quickly gain first mover advantage. PPC's
sophisticated technology platform allows the company to create additional
revenue streams with minimal cost by accessing enhanced service modules as
market demand changes. This scaleable architecture creates even greater
profitability by enabling multiple services to be delivered over the PPC service
delivery platform.

         Management believes that PPC is primed to swiftly react to the
ever-changing healthcare industry. Unlike the costly, capital-intensive and
stand-alone products offered by our industry competitors, PPC's sophisticated
platform offers flexible solutions and functionalities that are universal enough
to have broad appeal while still allowing for a level of customization that is
necessary to integrate with a hospital's existing legacy system, and at an
affordable cost. Our flexible platform also enables the healthcare providers to
fulfill the government's newest mandates for a full "continuum of care" from the
hospital to the home. This unique ability enables PPC to present a tailored
solution to our customers at a cost-effective price and will dramatically
enhance our ability to capture significant market share nationwide.

         PPC's expertise is in its ability to create win-win opportunities for
hospitals and patients by clearly defining customized, flexible, and integrated
healthcare solutions with measurable results. PPC enables hospitals to improve
patient flow, enhance patient satisfaction, and create long-term relationships
with patients as they move from hospital to home. In so doing, hospitals gain
productivity and efficiency enhancements, reduce the burden on staff and
increase cash flow by optimizing reimbursements from third-party sources.


                                      -17-
<PAGE>

PATIENT PORTAL PRODUCTS AND SERVICES
------------------------------------

         Many hospitals are plagued with decentralized workflows and vertical
silos of information that create redundant, costly processes and a disjointed
patient experience. Competition and consumers are demanding change.

         PPC addresses that need for change with customized solutions that
improve efficiency and productivity of administrative processes directly
affecting the patient relationship and the hospital's ability to generate
revenue. Hospitals gain real-time reports, reallocation of labor hours,
improvements in productivity and revenue, opportunities to enhance customer
service, enhanced branding, and compliance with government directives to measure
outcomes. The sophistication of our system core elements can be integrated into
any hospital nationwide while allowing for cost-effective customization to meet
the specific needs of each institution.

         o PPC was created as an outcome of working with our hospital partners
in a live laboratory to create process solutions that are cost-effective,
scalable, and allow for seamless and transparent integration into the hospital's
legacy systems and culture.

         o Our workflow and patient management systems bring the hospital in
compliance with Joint Commission on Accreditation of Healthcare Organizations
(JCAHO) mandates, which boost the hospital's pay-for-performance reimbursements.

         The following is a brief description of the principal services
delivered by PPC:

Patient Tracker Services:
-------------------------

         Having the right patient in the right place at the right time is a key
tenet of business in healthcare. That can be difficult and costly when up to 60
percent of all admissions come through the Emergency Department and are
unplanned. Coordinating efforts of interdepartmental staff involved in patient
flow is challenging when hospitals continue to work with paper slips and white
boards to determine room availability. Inefficiency is costly considering each
patient who leaves or is diverted from the ED costs the hospital $15,000 or
more. With overcrowding and Emergency Department diversions becoming the norm,
hospitals are searching for innovative, cost-effective ways to manage patient
throughput.

         In support of this trend, the Joint Commission on the Accreditation of
Health Care Organizations (JCAHO) issued a standard in January 2005, Managing
Patient Flow (LD.3.15). This standard measures leadership progress towards
development and implementation of plans to identify and mitigate impediments to
efficient patient flow throughout the hospital.

         Patient Tracker is PPC's direct response to address this critical
industry-wide challenge. Patient Tracker was developed with guidance from one of
the most respected technology hospitals in the industry. The system provides
real-time information on the current location of all patients by collecting and
displaying critical-path information within departments and hospital-wide. The
interactive screens provide each member of the care team with useful information
concerning critical tasks, room availability, messaging, and time-stamped
workflow. We have developed a user-friendly graphical interface that allows all
hospital stakeholders including nurses, administration, transport, and
housekeeping to determine patient location, room availability, and staff
performance. To minimize costs we have designed a centralized data management
architecture that allows hospitals to share in the savings of networked based
capabilities and realize a documented ROI of less than 12 months.


                                      -18-
<PAGE>
         Patient Tracker provides quantitative and qualitative data that allows
administrators to predict trends and determine best use of critical resources.
Further, the system is flexible and scalable for customized integration into any
hospital's legacy systems and culture. The Patient Tracker system's
effectiveness is further enhanced by a unique module, ED Tracker, unmatched by
any software application in the industry. Made specifically for the Emergency
Department, this application seamlessly integrates with our hospital-wide
Patient Tracker system and is customized to provide for transparent use within
the hospital's current process flow.

Patient Relationship Services:
------------------------------

         The typical flow of information through a hospital can often stop at
the front line since nurses hear most patients' needs--medical and
non-medical--but have little time to react to anything beyond medical concerns.
In all facets of healthcare, effective communication with patients and
addressing their non-medical needs are often bypassed for more pressing medical
issues...until recently. Industry studies continue to prove that there is a
direct correlation between effective patient communication and improved medical
outcomes. The shift toward improved patient satisfaction can be enhanced further
if patients are given a means of controlling their hospital environment and if
information about patients can be shared among caregivers.

         Stimulated by this trend, new JCAHO mandates call for improved patient
communication and management with 2007 National Patient Safety Goals, "Improve
the effectiveness of communication among caregivers (Goal 2)," "Encourage
patient's active involvement in their own care...(Goal 13)," and "Define and
communicate the means for patients and their families to report concerns about
safety...(Goal 13A)." As hospital compliance with these goals determines
pay-for-performance reimbursements, administrators put high value on process
improvements that enhance patient communication, customer service, and process
efficiency.

         To meet these needs and requirements, PPC has developed the following
patient relationship services:

         Scheduler Elite: A suite of innovative and elegantly simple
applications designed to collect and display scheduling data on a "real-time"
basis within departments and enterprise-wide. Scheduler Elite is a
comprehensive, web-based patient management application featuring interactive
data controls that allow multi-user simultaneous access so doctor's offices,
hospital departments, and scheduling services can share and collect patient data
across multiple platforms. Scheduler Elite's unique configurability incorporates
processes to facilitate compliance and best practices. PPC retains extraordinary
value by gaining multiple patient touch points, integrating 24/7 call coverage,
and hosting the application and data.

         ConnectMD: This is a innovative service platform which provides nearly
effortless customer service for patients on behalf of the heathcare institution,
ensuring consistent communication with patients, which closes the loop between
medical offices, patients, and the hospital after hours or during ED overflow
when a timely response can be critical. ConnectMD features live-answer contact
with our Patient Contact Representatives and custom scripting for the doctor's
office or hospital department. ConnectMD provides a third communication option
for our varied customer base beyond web and electronic systems.


                                      -19-
<PAGE>
         Physician Finder: The advanced technology of Physician Finder
seamlessly integrates with the hospital databases to create a customized
application for instantaneous data queries across multiple matrices matching
physicians with patient criteria. The sophistication of this platform supports
enhanced customer service initiatives, such as an automatically generated letter
or email listing the selections and personalized directions to the medical
offices from the patient's specified address. Further, all patient data and
physician selections can be queried and cross matched in real-time reports for
more focused marketing and targeted education to the patient.

         Instant Response Line: An interactive, live response solution that
enables patients to log a non-medical need, which is electronically transferred
to an appropriate hospital department for resolution in a timely fashion.
Putting the hospital in proactive mode, improves interdepartmental
communication, and adds an unparalleled level of customer service for the
patient. A key element to the success of this system is time-stamped reporting
that allows administrators to see how quickly and efficiently their staff
responds. Administrators can request immediate notification regarding certain
calls for direct intervention and response. Instant Response Line provides a
single point of contact for all patient problems and leads to greater patient
satisfaction.

         Quick Pulse Surveys: Quick inpatient surveys allow hospital
administrators to keep their "finger on the pulse" of what patients are thinking
while in house--a vastly different concept from industry standard post-discharge
surveys hospitals typically employ. This customized service focuses on finite
issues, allowing the hospital to direct specific, timely solutions. A key
differentiator between our service and competing survey services is our ability
to collect patient response data in real time while the patient is still
involved in the experience. The data is also made available in real-time with
follow-up analysis available so hospitals can benchmark and measure
improvements, putting the hospital in compliance with pay-for-performance
government initiatives.

         Outcomes Optimizer: Nationally, the prevalence of medical errors
related to the discontinuity of care from the inpatient to the outpatient
setting is high and may be associated with an increased risk of
re-hospitalization. Further, more than one in five seniors take five or more
different prescription drugs every day. The difficulty in coordinating medical
care among providers is exacerbated with poor communication vehicles and
disparate technology systems making continuity of care nearly impossible.

         To address this pressing concern, beginning in 2008, the Joint
Commission on the Accreditation of Healthcare Organizations (JCAHO) requirements
mandate hospitals to implement processes that manage patient treatment across
the full continuum of care from hospital to home and between all caregivers. To
satisfy requirements for successful accreditation and pay-for-performance
reimbursements, hospitals must look outside the traditional healthcare paradigm
to create a broader spectrum of care and communication.

         In direct response to one of healthcare's most critical needs, Patient
Portal Connect's Outcomes Optimizer is a revolutionary system that enables
incongruent providers to coordinate efforts across a full continuum of care.
Outcomes Optimizer effectively bridges the communication gaps between providers
with multi-layered architecture that coordinates tasks and patient information
in real time. Our state-of-the-art system gains us strategic competitive
advantage with applications that qualify and quantify critical patient data and



                                      -20-
<PAGE>

measure improvements in patient outcomes to ensure hospital reimbursements for
JCAHO compliance in 2008. We are positioned ahead of the curve enabling
hospitals to proactively address preventative medicine and wellness education
among caregivers from the hospital to the home with remote diagnostic
monitoring, wellness education, and medication monitoring. These services
provide a continuum of support and position us to be at the forefront of
outcomes-based requirements for healthcare.

         A critical component of our Outcomes Optimizer is the ability to
provide feedback to physicians and close the communication loop with web-based
access to patient information for home healthcare providers, hospitals, and
physicians. To ensure the discharge management process continues the hospital's
relationship with the patient at the home, our Outcome Optimizer system provides
critical data feedback and continuous, real-time patient data flow to multiple
providers after discharge. These factors are distinctive to our services and
emphasize a private-branded full continuum of care for the hospital.

VIRTUAL NURSE(TM) MARKETING AGREEMENT
-------------------------------------

         In April, 2007, the Company acquired a minority interest in Virtual
Nurse, Inc. of Palm Beach Gardens, FL, and entered into a joint Marketing
Agreement to introduce Patient Portal and Virtual Nurse(TM) services to
healthcare institutions throughout the United States.

         Virtual Nurse's mission is to provide healthcare organizations with
efficient, cost-effective nursing solutions. It offers the highest quality of
care through experienced, skilled, productive, and motivated nurses who benefit
from the convenience of working at home on a flexible time schedule. As a
result, it is able to give healthcare facilities assurance that every patient
receives condition-specific education before entering their facilities and
ensure that every assessment has been carefully documented and delivered on
time.

         Virtual Nurse's PASS (Pre-Admission Screening Services) program
fulfills a critical need in the healthcare industry as expenditures continue to
increase and nursing shortages become greater. Virtual Nurse offers the
expertise of registered nurses without the challenges or costs of adding on-site
staff. Virtual Nurse's RNs perform the administrative medical screening tasks
usually conducted by registered nurses in a healthcare facility, with one
important distinction: their RNs are dedicated to this service seven days a
week, including extended hours, while hospital nurses attempt to contact
patients during abbreviated calling hours.

         Virtual Nurse enables healthcare providers to reallocate all available
RNs to medical areas where they are needed most, free from the time-consuming
administrative responsibilities of calling patients and coordinating paperwork.
Further, the perception to patients is that the healthcare facility is the
service provider. Therefore, the healthcare facilities gain improved patient
care and satisfaction, superior customer service, and enhanced brand image.

HEALTHCAST(TM) PATIENT NETWORK SYSTEM LICENSE AGREEMENT
-------------------------------------------------------

         As part of its healthcare services package, PPC has recently begun to
market the newly-developed HealthCast Patient Network System under an exclusive
technology license from Omnicast, Inc. HealthCast is the first suite of



                                      -21-
<PAGE>
customized hospital television channels that invites viewers to interact with
channel programming and delivers condition-specific content directly to a
patient's TV, IP phone, or home computer. HealthCast features an exclusive
digital signage platform that promotes an unparalleled level of communication by
simultaneously showing video, an information scroll, and additional customized
messaging to a single patient, certain patient groups, or to specific areas of
the hospital. HealthCast is the only patient network that puts the hospital in
control of multiple information streams for an unprecedented level of
communication and education for patients and families. In addition, HealthCast's
proprietary platform captures viewing metrics so hospitals can document
educational content delivery for pay-for-performance reimbursement, and
commercial sponsors can respond to patient viewing habits

         HealthCast's Foundation Channel, Education Services Channel, and MyMail
station present personalized content to specific patients In turn, patients have
opportunities to interact with the multimedia platform to respond to channel
content, such as with live auctions on the Foundation Channel, text messaging or
E-Greetings on MyMail, or by answering questions to win prizes after watching
condition-specific educational programming. The Foundation Channel promotes
fundraising events and announcements with celebrity endorsements and national
sponsorship.

EMPLOYEES
---------

         As of June 30, 2007, the Company currently has seven full-time
employees and three part-time employees. In addition, the Company contracts for
24/7 Operator Call Center and Data Management Services with Worldnet
Communications, Inc. of Syracuse, NY. The Company's sales and marketing is
primarily conducted through a Master Dealer Agreement with VOX Technologies,
Inc., which utilizes over one hundred independent dealer representatives
throughout the United States to market the Company's products and services to
healthcare institutions on a commission-only basis.

LIQUIDITY AND CAPITAL RESOURCES
-------------------------------

         As shown in the above financial statements, the Company incurred a net
loss of ($401,408) during the year ended December 31, 2006 and ($182,881) during
the three months ended June 30, 2007. The Company plans to raise more capital
through public or private financing, through the issuance of its common stock,
the issuance of debt instruments, including debt convertible to equity, or
otherwise attain financing, which if available, it cannot be certain such
financing will be on attractive terms. Should the Company obtain more capital,
in turn, it may cause dilution to its existing stockholders and providing the
company can obtain more capital, it cannot be assured to ultimately attain
profitability. These factors create substantial doubt as to the Company's
ability to continue as a going concern.

         The Company intends to continue its efforts to complete the necessary
steps in order to meet its cash flow requirements throughout fiscal 2007 and to
continue its product development efforts and adjust its operating structure to
reduce losses and ultimately attain profitability. Management's plans in this
regard include, but are not limited to, the increase in business operations
which it expects from the acquisition of additional retail hospital contracts by
its Patient Portal Connect subsidiary and the continuing roll-out of its product
line to its existing and future customer base.




                                      -22-
<PAGE>

         Management believes that actions presently being taken will generate
sufficient revenues to provide cash flows from operations and that sufficient
capital will be available, when required, to permit the Company to realize its
plans. However, there can be no assurance that this will occur. The accompanying
financial statements do not include any adjustments that might result from the
outcome of this uncertainty.

INFLATION

         The rate of inflation has had little impact on the Company's results of
operations and is not expected to have a significant impact on continuing
operations.



ITEM 3.  CONTROLS AND PROCEDURES

         Under the supervision and with the participation of management
including the Chief Executive Officer and Chief Financial Officer, we have
evaluated the effectiveness of the design and operation of our disclosure
controls and procedures pursuant to Exchange Act Rule 13a-14c and of the end of
the period covered by this report. Based on that evaluation, the Chief Executive
Officer and Chief Financial Officer have concluded that these disclosure
controls and procedures are effective. There were no changes in our internal
control over financial reporting during the quarter ended March 31, 2006 that
have materially affected, or are reasonably likely to materially affect, our
internal controls over financial reporting.








                                      -23-
<PAGE>

                                     PART II
                                     -------

OTHER INFORMATION


ITEM 1.  LEGAL PROCEEDINGS.

         The Company is at present not involved in any legal proceedings which
management believes will have a material effect upon the financial condition of
the Company, nor are any such material legal proceedings anticipated. The
Company is presently negotiating with a judgment creditor to repay on negotiated
terms a promissory note in the amount of $300,000 plus accrued interest and
costs. In the event that the judgment is not satisfied, or successfully
renegotiated, the creditor will have the right to execute upon its judgment.
Based upon the original terms of its Promissory Note, the creditor also retains
the right to convert the principal amount of said judgment into shares of Common
Stock at a conversion price of $1.00 per Share.


ITEM 2.  CHANGES IN SECURITIES.

                 NONE


ITEM 3.  DEFAULTS UPON SENIOR SECURITIES.

                  NONE


ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

                  NONE


ITEM 5.  OTHER INFORMATION.

                  NONE


ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K.

         Exhibit 31.1 31.2 32.1 32.2 - Officer Certifications

         Reports on Form 8-K:  NONE









                                      -24-
<PAGE>
                                   SIGNATURES
                                   ----------

         In accordance with the requirements of the Section 13 or 15(d) of the
Securities Exchange Act of 1934, the registrant, caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.

                        Patient Portal Technologies, Inc.

Dated: August 10, 2007
                                         By: /s/ KEVIN KELLY
                                         ----------------------------
                                         Kevin Kelly, President

         Pursuant to the requirement of the Securities Exchange Act of 1934,
this report has been signed by the following persons on behalf of the Registrant
and in the capacities and on the dates indicated.

NAME                                   TITLE                           DATE
-------------------------------------------------------------------------------

By: /s/ KEVIN KELLY                    President,                    8/10/07
    -----------------------            Chairman of the
     Kevin Kelly                       Board of Directors


By: /s/ THOMAS HAGAN                   Acting Chief Financial
    -----------------------            Officer, Director             8/10/07
     Thomas Hagan


By: /s/ DANIEL COHOLAN                 Director                      8/10/07
    -----------------------
     Daniel Coholan

















                                      -25-









--------------------------------------------------------------------------------